Amyotrophic Lateral Sclerosis: An Evaluation of Current Treatments and Multidisciplinary Approaches to Care

Released On
May 13, 2020

Expires On
May 13, 2021

Media Type

Completion Time
60 minutes

Neurology, Primary Care

Amyotrophic Lateral Sclerosis

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

This activity is supported by an educational grant from Mitsubishi Tanabe Pharma America, Inc..

Credit Available

  • Physicians — maximum of 1.00 AMA PRA Category 1 Credit(s)
  • Nurses — 1.00 Contact Hour

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This educational program is directed toward neurologists, internists, and other health care professionals involved in the treatment of patients with amyotrophic lateral sclerosis (ALS), such as primary care providers, nurse practitioners, and physician assistants.

Activity Overview

Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive neurodegenerative disorder that affects upper and lower motor neurons, causing muscle weakness and eventually resulting in paralysis and death. This review features Lora L. Clawson, MSN, CRNP, and Terry D. Heiman-Patterson, MD, who provide a disease overview, with a focus on current treatments, and the important of a comprehensive multidisciplinary care approach to the care of patients with ALS.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Characterize the etiology and pathophysiology of ALS and describe the process of making the ALS diagnosis
  • Outline strategies to manage patients’ ALS-related symptoms and quality-of-life issues as part of a multidisciplinary treatment team
  • Explain the safety and efficacy of disease-modifying and symptomatic pharmacotherapies for patients with ALS


Terry D. Heiman-Patterson, MD

Professor of Neurology
Director MDA ALS Center of Hope
Department of Neurology
Temple University Lewis Katz School of Medicine
Philadelphia, PA

Lora L. Clawson, MSN, CRNP

Director of ALS Research and Clinical Services
Assistant Professor, Department for Neurology
Johns Hopkins University School of Medicine
Baltimore, MD

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Disclosures of Conflicts of Interest

In accordance with ACCME guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Terry D. Heiman-Patterson, MD

  • Grant Research Support: Clinical trials for Amylyx Pharmaceuticals, Cytokinetics, MT Pharma America, Orion
  • Consultant: Biohaven Pharmaceuticals, Cytokinetics, ITF Pharma, MT Pharma America

Lora L. Clawson, MSN, CRNP

  • Grant Research Support: MDA Clinic Grant
  • Consultant: ALJ Nurse Practitioner, Allied Health Advisory Board Meeting Mitsubishi Tanabe Pharma America, Inc.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.